Veeva Systems Inc.

Veeva Systems finished the year on a strong note with both, its revenues as well as earnings exceeding the expectations of analysts as well as the management. The company’s financial performance for the quarter and year was solid. The management claims that it was a watershed year for clinical data management, with significant momentum in emergent areas like Safety, Link, and Compass. The company’s innovation engine is powerful, and it is expanding its strategic ties with the industry. Their guidance for fiscal 2024 guidance and preliminary fiscal 2025 advice appears positive and they look to offer context for the TFC-related one-time revenue impacts in 2024. The management anticipates sales growth of roughly 15% in fiscal 2024 and at least 15% in fiscal 2025 after adjusting for TFC and foreign exchange which indicates a very positive outlook. We give Veeva Systems a ‘Hold’ rating with a revised target price.